Business
Primary and Secondary endpoints met in MPS I Trial
Primary and Secondary endpoints met in MPS I Trial
About this update from Paradigm Biopharmaceuticals Ltd.
[{"type":"text","content":"Paradigm Biopharmaceuticals Ltd has released a press release. View Attachment","length":257,"tagName":"div"}]